JAMUNARANI VEERARAGHAVAN to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications JAMUNARANI VEERARAGHAVAN has written about In Situ Hybridization, Fluorescence.
Connection Strength
0.111
-
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer. Ann Oncol. 2019 06 01; 30(6):927-933.
Score: 0.111